1-800-710-4674

Blog Post

Return to News

Feature Story

 
Kill Cancer Syringe OHC Cincinnati

One Injection Could Kill Cancer

By Maria Cohut, Medical News Today. Review and Comments by Zaw M. Bo, MD, medical oncologist with OHC, Blogs, 2 comments
February 15, 2018

 
Bo-Zaw-Min-2017-OHC

Zaw M. Bo, MD
Medical Oncologist with OHC

Scientists experimenting with an innovative treatment for cancer have now devised a targeted injection that has already successfully eliminated tumors in mice.

“Researchers have been looking at the ability to treat tumors using an injection directly into a tumor,” said Zaw M. Bo, MD, medical oncologist with OHC. “No one knows for sure just yet whether this could work, but it does seem promising given the fact that it’s been effective in laboratory tests on mice.”

The latest study, from Stanford University School of Medicine in California, has investigated the potential of injecting microscopic amounts of two agents that stimulate the body’s immune response directly into a malignant solid tumor.

So far, their studies using mice have proven successful. “When we use these two agents together,” explains senior study author Dr. Ronald Levy, “we see the elimination of tumors all over the body.”

Moreover, the researchers have reason to believe in a speedier path toward clinical trials for this method, since one of the agents involved has already been approved for use in human therapy, while the other is already under clinical trial for lymphoma treatment.

The study’s findings were published February 2, 2018 in the journal Science Translational Medicine.

Dr. Levy specializes in the use of immunotherapy — which is a type of treatment wherein the body’s immune response is enhanced so that it can target cancer cells — to fight lymphoma, or cancer of the lymphatic system.

There are several types of immunotherapy, including some that boost the entire immune system of the body and others that are a lot more targeted. But, the researchers note, they all come with caveats attached. They may have problematic side effects, be time-consuming, or be simply too costly. The team’s method, however, arguably has more benefits — even beyond its potential effectiveness as a treatment.

“Our approach uses a one-time application of very small amounts of two agents to stimulate the immune cells only within the tumor itself,” Dr. Levy explains. This method can “teach” immune cells how to fight against that specific type of cancer, which then allows them to migrate and destroy all other existing tumors.

Although the immune system’s role is to detect and eliminate harmful foreign bodies, many types of cancer cell are able to evade detection in complex ways, which enables them to grow and spread.

“Once again, this demonstrates the life-changing role research and clinical trials play in the quest to eradicate cancer,” added Dr. Bo.

Read the entire article here.

 
 

Leave a Reply

Your email address will not be published. Required fields are marked *

2 Responses

  1. Kevin Bartels says:

    I have Stage 4 oesophagus cancer and I’m wondering whether you’re immune injection would work I am willing to fly to America to have this treatment

    • OHC says:

      Dear Kevin,

      Thank you for your message. Medical News Today noted in their article that this treatment is still being tested by researchers at Stanford University School of Medicine in California. The researcher is Dr. Ronald Levy. I searched Stanford’s website and found this contact information for Dr. Levy:

      Academic Tel: (650) 725-6452
      Clinical Lymphoma Clinic
      875 Blake Wilbur Dr, Clinic C
      Stanford, CA 94305
      Tel: (650) 498-6000
      Fax: (650) 725-9113

      This link will take you to his profile on the university’s web site: https://med.stanford.edu/profiles/ronald-levy

      I would contact Dr. Levy for all the details since he is leading this research.

      Best of luck to you.